Mar 17, 2025 | London BioScience Innovation Centre, Member News
London BioScience Innovation Centre (LBIC) is delighted to welcome Laverock Therapeutics (Laverock) to its new facility at the Apex Building, Tribeca London. The company has taken up occupation of its new 4,133 sq ft fully fitted lab and office space within...
Aug 19, 2024 | London BioScience Innovation Centre, Member News
London BioScience Innovation Centre (LBIC) is delighted to announce that it has entered into an Agreement for Lease with Baseimmune Ltd. The novel vaccine developer will occupy 3,350 sq ft of lab and office space in LBIC’s new, fully fitted, grow-on space within the...
Nov 14, 2022 | London BioScience Innovation Centre, Member News
The London BioScience Innovation Centre (“LBIC”) will open a new 37,127 sq. ft. (GIA) state-of-the-art innovation centre at The Apex, one of five mixed-use buildings within the ‘Tribeca’ development in the heart of King’s Cross being delivered by Reef Group and...
Mar 2, 2022 | London BioScience Innovation Centre, Member News
Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to treat cancer, announced it has secured £30.75 million ($41.20 million) in an oversubscribed Series B financing round. The round was led by new investor Novartis Venture...
